Experience

Peerbridge Health

• United States
• Hospitals and Health Care
• 1 - 100 Employee

• National Sales Director

  • Feb 2022 - Present

  Developer of the Cor Ambulatory ECG monitor. Patented wireless patch design offering 2 channels with derived 6 leads providing ~60 % more arrhythmia detection and diagnostic capabilities such as EF % from ECG and AHI from ECG. • Spearheaded strategic growth for Cor by collaborating with key EP/Cardiologists within the Northwell Health System in New York. • Achieved a record number of patient enrollments in 2022, surpassing previous year’s figures.• Successfully secured services of renowned EP/Cardiology Key Opinion Leaders (KOLs) to join Peerbridge Health's 'Scientific Advisory Board' for the development of Cor 2.0 technology, focusing on treatment objectives with ejection fraction (EF) % estimation and apnea-hypopnea index (AHI) capabilities.• Strategically planned the roll-out for geographical field sales (direct and indirect) to drive market development.• Successfully negotiated budget agreements for 'EF from Cor ECG' clinical trials with Healthcare Corporation of America (HCA) and Orange County Heart Institute in CA. Show less

• Director of Sales

  • Feb 2022 - Jan 2023



YorUltrasound

• Management Consultant

  • Nov 2019 - Jul 2021

  Developer of a Software Enabled Ultrasound (SEU) solution that re-defines Ultrasound Imaging via an ultraportable-handheld whole-body wireless probe for universal diagnostic care. • Steered commercialization plan to enhance brand visibility among traditional customers and Medicare Administrative Contractors, as well as preliminarily engaging Commercial and Private Insurers. • Identified key performance indicators (KPIs) to expand services and acquire new customers. • Developed sales and marketing plans, implemented multi-market access strategies, and conducted analysis of procedural coding and reimbursement aspects. Show less



Cardiac Insight, Inc.

• United States
• Medical Equipment Manufacturing
• 1 - 100 Employee

• Director of Sales, Eastern U.S.

  • Jan 2015 - Jul 2018

  Developer of CARDEA 20/20 ECG and SOLO patch. 12-Lead and 7-Day wearable ECG Sensor Technology & Proprietary Software within the Cardiology, EP and Sports Medicine disciplines for remote patient monitoring in the detection of serious, often asymptomatic, life-threatening arrhythmias. • Orchestrated a comprehensive market analysis of the Cardiac Arrhythmia Detection Market. • Owned all aspects of Sales Planning, Team Development, and Account Management. Implemented sales team strategies and KPIs to increase brand awareness. • Directed Revenue Growth Strategy of CARDEA 20/20 and SOLO products with 18 Indirect Representatives and 3 Region Managers spanning 16 Eastern U.S. States. • Enabled enduring adoption of Cardiac Insight ECG technologies through the formation of strategic partnerships with influential Hospitals/IHNs, Cardiologists, Sports Cardiologists, NCAA University Athletic Departments, Professional Sports Teams (NFL-NBA-NHL-MLB), and Youth Advocacy Organizations, resulting in the sustained incorporation of Cardiac Insight ECG Technologies. • Procured national distribution agreement with Henry Schein-Sports Medicine Division. • Fostered new relationships with University Hospitals, their Clinical Study sectors, and industry CROs. • Grew market penetration and sales figures by leveraging Distributor relationships and personally overseeing negotiations resulting in 150% revenue increase vs. Plan with High Schools, Colleges, and Universities. • Secured renowned EP/Cardiology KOL services for Cardiac Insight “Scientific Advisory Board”. Show less



Halt Medical Inc. - Acessa Procedure

• United States
• Medical Equipment Manufacturing

• Sr. Director, Health Economics and Reimbursement

  • Jan 2014 - Dec 2015

  In Women’s Health – the Acessa Procedure employed RF Ablation technology for fibroid treatment, affording an alternative therapy to Hysterectomy. • Served as the Principal Market Access Liaison for Physicians, Staff, Facility and Halt Field Sales Management. • Communicated Acessa procedural Economic Value Proposition and enhanced patient QOL findings to Commercial Payers, Surgeons, Facilities, and C-Suite executives. • Devised implementation strategies & assisted in Clinical Dossier preparation for Payer Non-Coverage Policies. • To support Acessa Value-Proposition, devised and implemented a “Hospital/ASC Financial Model,” in tandem with the situational viability of Facility billing HCPCS for “Non-Routine High-Cost” disposables. • Built Reimbursement toolkit to support project initiatives, training sessions, and administrative activities. • Surpassed Surgeon adoption and Procedure Benchmarks in 2015. Acessa adoption rates increased by 250% vs. previous year. Show less



SI-BONE

• United States
• Medical Device
• 300 - 400 Employee

• Director, Market Access & Reimbursement-East

  • Jan 2011 - Dec 2013

  Developer of the iFuse Implant System for sacroiliac joint fusion in the treatment of chronic lower back pain. Partnered with Field Sales to address the barriers to Surgical Utilization and Adoption. Supported Field Sales Team by educating Surgeons, Hospitals, and Ambulatory Surgery Centers staff on the Economic Value Proposition and QOL enhancements of the iFuse Implant System. • Formally presented the iFuse Clinical, Economic Value proposition and patient QOL findings to Regional Payer Medical Directors. • Developed and maintained relationships with Payers through consistent communication paving the way for Medical Policy approvals. • Conceptualized and implemented the “Hospital/ASC Financial Model,” streamlining dialogue with C-Suite Executives and Technology Evaluation Committees (TEC). • Coordinated “Pre-Auth” Protocols and Reimbursement activities between Physician Offices and 3rd Party Case Management group. • Recruited and coordinated Surgeon KOL support for regional Payer meetings. • Expanded cross-functional organizational capacity by collaborating across departments on priorities, events, and common goals. Show less